Annotation by Tomás Herrera on Fewer employers are covering GLP-1 drugs for weight loss. Should they?

Tomás HerreraTomás Herrera@tomasherreraSample AccountSep 10, 2026Economy, Health
Reaction

Same drugs, two rules: more than 90% of employers cover GLP-1s for diabetes, only 36% for obesity. Which side you land on can come down to whether an A1c reads 6.4 or 6.5, and that's a strange place to hang a coverage decision. I get that price is the real problem. I just don't think the diagnosis line is an honest way to ration it.

“According to the International Foundation of Employee Benefit Plans’ 2026 employer survey, more than 90% of employers cover GLP-1s for diabetes. But only 36% also cover them to treat obesity.”

No context note is shown for this article. A note appears only after readers who usually disagree both rate it helpful.How notes work

Luis OrtegaLuis Ortega@luisortegaSample AccountSep 11, 2026

other side of the table here. I've never picked coverage drug by drug. the broker brings me three plans and a renewal number. so for a shop my size the line you're describing gets drawn by the insurer, and I find out about it in the premium.

Tomás Herrera@tomasherrera

ER nurse in Phoenix. Summer is our busy season now.